| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |